Migraine: Triggers, Treatment, and the Painkiller Trap

What makes migraine different from a bad headache?

Migraine is a neurological disorder that causes recurrent attacks of head pain alongside other symptoms including nausea, vomiting, and sensitivity to light and sound. It differs from tension headache not just in intensity but in mechanism: a migraine attack involves a wave of electrical and chemical change across the brain followed by neurogenic inflammation of the blood vessels around it. The Global Burden of Disease Study 2023, published in Lancet Neurology, ranks migraine as the leading cause of years lived with disability in adults aged 15 to 49.

A classic migraine attack passes through four stages. The prodrome, which arrives hours or even days before the headache, includes symptoms like fatigue, mood change, food craving, or yawning. The aura, experienced by roughly a third of sufferers, involves neurological symptoms such as visual disturbances, tingling, or speech difficulties that last 20 to 60 minutes. The headache phase itself typically causes throbbing one-sided pain that worsens with movement. The postdrome leaves many people exhausted and mentally foggy for the rest of the day even after pain resolves.

Many people with migraine go undiagnosed for years, often because their attacks do not fit the textbook pattern. A 2025 cross-sectional study of the Arab general population published in The Journal of Headache and Pain found a significant burden of undiagnosed migraine, with many sufferers managing their attacks with over-the-counter analgesics and never receiving specific treatment. A 2020 systematic review of migraine epidemiology across Arab countries estimated that 12 to 15 percent of the adult population is affected, with a female-to-male ratio of roughly three to one.

What are the most common migraine triggers?

Identifying personal triggers is the most productive step in long-term migraine management. A study by Kelman published in Cephalalgia in 2007, documenting triggers in over 1,200 migraine patients, found that psychological stress was reported by more than 70 percent of sufferers as a trigger, followed by sleep disturbance, skipped meals, bright lights, and strong smells. Hormonal fluctuation in women, particularly the drop in oestrogen just before menstruation, is one of the most powerful and reliable triggers.

In the regional context, Ramadan fasting creates a simultaneous disruption to sleep timing, meal timing, and hydration, all three of which are established migraine triggers. Extreme summer heat and the dehydration it produces are additional regional factors. Air conditioning that significantly dries indoor air and the smoke from shisha pipes are also frequently reported by patients in the region as attack precipitants.

The dietary trigger list that circulates in popular health content, including chocolate, aged cheese, red wine, and coffee, should be interpreted with caution. The evidence for most of these as direct triggers for all sufferers is weaker than commonly presented. What is consistently supported is that skipping meals is more dangerous than any specific food. Hunger narrows cerebral blood vessels and reliably precipitates attacks. Keeping meal intervals regular, at no more than four hours, is one of the highest-value simple interventions.

Treating an acute attack: how triptans differ from painkillers

Ordinary analgesics such as paracetamol and ibuprofen work by blocking general pain signalling pathways. They are useful for tension headache but are significantly less effective for migraine because they do not address the underlying neurological mechanism of the attack. Triptans work differently: they bind to specific serotonin receptors on cerebral blood vessels and trigeminal nerve endings, reducing the neurogenic inflammation that drives migraine pain.

A systematic review and network meta-analysis published in Headache in 2015, covering dozens of clinical trials, found that triptans were substantially more effective than simple analgesics at achieving two-hour pain freedom in migraine. The most widely available in the region is sumatriptan, which comes as tablets, a nasal spray, and a subcutaneous injection. Effectiveness is highest when the medication is taken at the very first sign of the headache, before pain becomes established.

Triptans are not appropriate for everyone. People with a history of coronary artery disease, stroke, uncontrolled hypertension, or haemiplegic migraine should not use them without medical guidance. Taking a triptan more than ten days per month also carries the risk of contributing to medication overuse headache, the same trap that catches people using ordinary painkillers too frequently.

The painkiller trap: when the medicine becomes the problem

Medication overuse headache (MOH), sometimes called rebound headache, develops when the brain adapts to frequent analgesic use by becoming more sensitive to pain in the absence of the drug. The result is that the headache appears every time a dose wears off, creating a cycle where the person takes more medicine to treat the headache that the medicine is now partly causing.

The practical threshold is that using any headache medication, whether paracetamol, ibuprofen, codeine-containing combinations, or triptans, on more than 10 to 15 days per month over an extended period creates significant risk of MOH. In many Arab countries where analgesics are freely sold without a prescription, this pattern is extremely common. Some compound tablets marketed for headache contain both an analgesic and caffeine, and caffeine's addictive properties make the overuse cycle particularly hard to break.

The only effective solution to medication overuse headache is a supervised withdrawal from the overused medication. This causes a predictable worsening of headache for one to two weeks, after which headache frequency typically falls significantly. The withdrawal should be managed by a doctor, particularly when the medication contains codeine or high-dose caffeine, as the dependence component requires careful tapering rather than abrupt stopping.

Migraine prevention: when to start and what is available

Preventive treatment means taking medication daily to reduce the number and severity of attacks over time, rather than only treating each attack as it occurs. It is recommended when someone has four or more migraines per month, when attacks consistently last more than 48 hours, or when a pattern of medication overuse has already developed. Starting prevention early prevents the transition from episodic to chronic migraine.

Established preventive medications include beta-blockers such as propranolol, anticonvulsants such as topiramate and valproate, and low-dose tricyclic antidepressants. The newer CGRP-targeting monoclonal antibodies are the most effective preventive treatments available and act directly on the neurological pathway that drives migraine, but they remain expensive and are not yet widely accessible in the region. A diagnosis and prescribing by a neurologist is needed for most preventive medications.

Preventive treatment takes six to eight weeks to show its full effect. Many patients stop too early, concluding that the medicine is not working. Keeping a headache diary during this period is essential so that the reduction in attack frequency can be seen and compared. The choice of preventive drug is often guided by coexisting conditions: a patient with hypertension may prefer propranolol, while someone with disturbed sleep may benefit more from a tricyclic antidepressant.

Migraine aura: what it means and when it should concern you

Aura refers to neurological symptoms that precede or accompany the headache in about a third of migraine sufferers. The most common form is visual: expanding arcs of shimmering light or blind spots that slowly grow over 20 to 30 minutes and then resolve. Sensory aura, causing tingling that spreads from the fingers up the arm, is less common. Language difficulty occasionally occurs and is particularly alarming because it mimics stroke.

The key clinical distinction from stroke is the evolution of aura over minutes. Aura symptoms begin small and spread gradually, reaching their peak over 20 to 30 minutes and then clearing within an hour. A stroke causes symptoms that appear suddenly at their full severity and do not resolve on their own. If you are uncertain, treat it as a possible stroke and seek emergency care, because the consequences of missing a stroke are far graver than the inconvenience of a false alarm.

Migraine with aura carries a modestly elevated risk of ischaemic stroke, particularly in women. This risk is further increased by oestrogen-containing combined oral contraceptive pills and by smoking. A woman who has migraines with aura should discuss contraceptive choices specifically with her doctor, as progestogen-only methods do not carry the same stroke risk elevation.

Red flag headaches: when to go to emergency immediately

Not every severe headache is migraine, and several secondary headache types signal emergencies that can be life-threatening if missed. The thunderclap headache, described by patients as the worst headache of their life appearing in seconds, is the classic warning sign of subarachnoid haemorrhage caused by a ruptured aneurysm. This is a medical emergency regardless of whether the person has a known history of migraine.

Other urgent presentations include headache with fever, neck stiffness, and marked photophobia, suggesting meningitis. Headache with one-sided limb weakness, facial drooping, or sudden speech difficulty should be treated as stroke until proved otherwise. Headache that progressively worsens over days or weeks, especially with personality change or morning predominance, raises the possibility of raised intracranial pressure from a space-occupying lesion and needs imaging.

A person with established migraine can still develop a new and different headache type. The rule to apply is: if this headache feels different from your usual attacks in quality, onset, severity, or accompanying symptoms, it needs medical assessment rather than assumption that it is just a worse migraine.

Living with migraine: the headache diary and what it teaches you

A headache diary is one of the most practical tools in migraine management because it transforms vague memories of bad weeks into objective data. For each attack, record the date and time, the pain severity on a scale of one to ten, any aura symptoms, what you ate and drank in the previous 24 hours, sleep quality the night before, stress level, and what medication you took and how long before it worked. After two to four weeks, patterns emerge that neither patient nor doctor could identify from memory alone.

The diary also provides the information needed for decisions about preventive treatment. The threshold of four migraines per month that triggers discussion of prevention sounds simple, but patients consistently undercount their attacks because mild attacks are forgotten. The diary prevents this and gives the clinician accurate frequency data. It also reveals medication overuse before the pattern becomes entrenched.

Sleep consistency is often underestimated as a prevention tool. Migraine responds badly to schedule change in either direction. Sleeping in on weekends after a week of late nights causes weekend headache through the combination of sleep excess and caffeine delay. Keeping the same wake time seven days a week, even if this means a shorter lie-in than usual, reduces attack frequency for many sufferers without any medication at all.

Sources

• El-Metwally A, Toivola P, AlAhmary K et al: The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review, TheScientificWorldJournal, 2020
• Elzayat MA, Kassab SA, Nada MAF et al: Burden of hidden migraine among the Arab general population: a cross-sectional study, The journal of headache and pain, 2025
• Robbins MS: Diagnosis and Management of Headache: A Review, JAMA, 2021
• Cameron C, Kelly S, Hsieh SC et al: Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis, Headache, 2015
• Kelman L: The triggers or precipitants of the acute migraine attack, Cephalalgia, 2007
• GBD 2023 Headache Collaborators: Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023, The Lancet. Neurology, 2025